Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nelarabine (GW 506U78) 是一种嘌呤核苷酸类似物,为DNA 合成抑制剂,对肿瘤细胞的IC50为0.067-2.15 μM,可作用于T 细胞急性淋巴细胞白血病。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 427 | 现货 | ||
2 mg | ¥ 616 | 现货 | ||
5 mg | ¥ 987 | 现货 | ||
10 mg | ¥ 1,960 | 现货 | ||
25 mg | ¥ 3,330 | 现货 | ||
50 mg | ¥ 4,860 | 现货 | ||
100 mg | ¥ 6,930 | 现货 | ||
500 mg | ¥ 13,900 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,090 | 现货 |
产品描述 | Nelarabine (GW 506U78) is a purine nucleoside analog and DNA synthesis inhibitor with IC50 from 0.067-2.15 μM in tumor cells. |
靶点活性 | DNA synthesis (PER-255 cells):0.067-2.15 μM |
体外活性 | The IC50 of Nelarabine is 25-fold and 113-fold higher than ARAC in T- and B-lineage, respectively. T-ALL cells are eightfold more sensitive to Nelarabine than B-lineage but there is considerable overlap. The efficacy of NEL in T-lineage and B-lineage cell lines is 25-fold and 113-fold less than ARAC, respectively. [1] Nelarabine acts by inhibiting DNA synthesis and inducing apoptosis in susceptible cells. [2]Nelarabine demonstrated significant antineoplastic activity with acceptable toxicity. [3] |
体内活性 | The Nelarabine plasma AUC is 2.82 mM minutes and the ara-G plasma AUC is 20 mM minutes. The terminal half-life of Nelarabine in plasma is 25 min, clearance is 42 mL/minutes/kg, and central volume of distribution is 1.1 L/kg. The terminal half-life of ara-G in plasma is 182 minutes and the central volume of distribution is 1.4 L/kg. In CSF the terminal half-life of Nelarabine is 77 minutes and of ara-G is 232 minutes. The AUCcsf:AUCplasma is 29 % for Nelarabine and 23 % for ara-G. Nelarabine and ara-G do not accumulate with daily infusions because of their relatively short half-lives. [4] |
细胞实验 | HSB2, ALL-SIL, JURKAT and PER-255 cell lines are tested for drug resistance using the MTT assay. Nelarabine are incubated over 4 days, with concentration tested in triplicate. The IC50 (drug concentration that inhibits cell growth by 50%) is used as the measure of drug resistance. Data represent the average of 2-6 experiments performed on separate occasions. In cases where 50% cytotoxicity is not achieved by even the highest dose in a particular experiment, the IC50 is recorded as double the highest concentration tested.(Only for Reference) |
别名 | GW 506U78, Nelzarabine, 奈拉滨, 506U78 |
分子量 | 297.27 |
分子式 | C11H15N5O5 |
CAS No. | 121032-29-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 3 mg/mL (10 mM)), Heating is recommended.
DMSO: 29.7 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 3.3639 mL | 16.8197 mL | 33.6395 mL | 84.0986 mL |
5 mM | 0.6728 mL | 3.3639 mL | 6.7279 mL | 16.8197 mL | |
10 mM | 0.3364 mL | 1.682 mL | 3.3639 mL | 8.4099 mL | |
DMSO | 20 mM | 0.1682 mL | 0.841 mL | 1.682 mL | 4.2049 mL |
50 mM | 0.0673 mL | 0.3364 mL | 0.6728 mL | 1.682 mL | |
100 mM | 0.0336 mL | 0.1682 mL | 0.3364 mL | 0.841 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Nelarabine 121032-29-9 Apoptosis Cell Cycle/Checkpoint DNA Damage/DNA Repair Nucleoside Antimetabolite/Analog DNA/RNA Synthesis HSB-2 Inhibitor T-ALL GW 506U78 acute lymphoblastic leukaemia MOLT-4 P12 DND41 Nelzarabine inhibit 奈拉滨 506U78 JURKAT inhibitor